Trypanosomiasis Relapse after Melarsoprol Therapy, Democratic Republic of Congo, 1982–2001
Recently, a high proportion of patients with late-stage Trypanosoma brucei gambiense trypanosomiasis, who had been treated with melarsoprol in some disease-endemic areas, subsequently relapsed. To determine whether the frequency of postmelarsoprol relapses increased over time, we reviewed data from...
Main Authors: | Jacques Pépin, Bokelo Mpia |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2005-06-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/11/6/05-0036_article |
Similar Items
-
Chimerization at the AQP2–AQP3 locus is the genetic basis of melarsoprol–pentamidine cross-resistance in clinical Trypanosoma brucei gambiense isolates
by: Fabrice E. Graf, et al.
Published: (2015-08-01) -
High Failure Rates of Melarsoprol for Sleeping Sickness, Democratic Republic of Congo
by: Jo Robays, et al.
Published: (2008-06-01) -
Human African Trypanosomiasis Transmission, Kinshasa, Democratic Republic of Congo
by: Gustave Simo, et al.
Published: (2006-12-01) -
African Trypanosomiasis Gambiense, Italy
by: Zeno Bisoffi, et al.
Published: (2005-11-01) -
Human African Trypanosomiasis in a Rural Community, Democratic Republic of Congo
by: Pascal Lutumba, et al.
Published: (2007-02-01)